FRA10AC1 polyclonal (C-term), anti-human
€0.00
In stock
SKU
AC-AP20372b
Catalog Number: AC-AP20372b
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB42861
Applications: WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB42861
Applications: WB
Datasheet
Request Information
Background:
The function of the C10orf4 protein is unknown. Expansion of a polymorphic CGG repeat within the 5'-UTR of the C10orf4 gene may be the cause of folate-sensitive fragile site FRA10A expression. Fragile sites appear visually as nonstaining gaps on chromosomes that are inducible by specific cell culture conditions.
Other Names:
Protein FRA10AC1, FRA10AC1, C10orf4
Target/Specificity:
This FRA10AC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 253-280 amino acids from the C-terminal region of human FRA10AC1.
Antigen Region:
253-280
Antigen Type: Synthetic Peptide
Gene Name: FRA10AC1
Gene ID: 118924
Primary Accession: Q70Z53
NCBI Accession: NP_660289.2
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
The function of the C10orf4 protein is unknown. Expansion of a polymorphic CGG repeat within the 5'-UTR of the C10orf4 gene may be the cause of folate-sensitive fragile site FRA10A expression. Fragile sites appear visually as nonstaining gaps on chromosomes that are inducible by specific cell culture conditions.
Other Names:
Protein FRA10AC1, FRA10AC1, C10orf4
Target/Specificity:
This FRA10AC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 253-280 amino acids from the C-terminal region of human FRA10AC1.
Antigen Region:
253-280
Antigen Type: Synthetic Peptide
Gene Name: FRA10AC1
Gene ID: 118924
Primary Accession: Q70Z53
NCBI Accession: NP_660289.2
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review